Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study descriptions and inclusion/exclusion criteria for a clinical trial on Non-Small Cell Lung Cancer, while adding new collaborators and a revision number.SummaryDifference13%
- Check26 days agoChange DetectedThe page now lists 250 research locations, with new sites added in Kingwood, Texas, and Santiago, Chile, while a site in Suwon, Korea, is currently recruiting. Additionally, the status of a site in Oslo, Norway, has been updated.SummaryDifference2%
- Check33 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-19.SummaryDifference0.3%
- Check41 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of February 19, 2025.SummaryDifference0.2%
- Check77 days agoChange DetectedThe study has increased its number of locations from 246 to 247, and the research site in Veracruz, Mexico has been marked as withdrawn. Additionally, the status of the study has changed from 'not yet recruiting' to 'withdrawn'.SummaryDifference2%
Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.